Skip to content
Recall Observatory FDA recall evidence

Drug product

WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and b) 18-count boxes (NDC 0363-1407-02, UPC 3 11917-20318 8) Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501,

D-0324-2020

October 01, 2019

Class III

Product summary

Firm
Sato Pharmaceutical Inc.
Event
Event 83964
Status
Terminated
Classification
Class III
Quantity
a) 112,104 units b) 24,696 units
Official record key
drug-enforcement:D-0324-2020

Official wording

Reason: Subpotent Drug

Code information: Lot #: a) AXWA, Exp. date Feb 2021; AXAB, Exp. date May 2021; AXLK, Exp. date Nov 2021; b) AXZP, Exp. date Jul 2021

Distribution pattern: Nationwide within the United States, Guam and Saipan

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent